arthrocare corp (ARTC:NASDAQ GS)
arthrocare corp (ARTC) Snapshot
|
Open
$33.48
|
Previous Close
$33.64
|
|
|
Day High
$33.71
|
Day Low
$33.17
|
|
|
52 Week High
01/29/13 - $36.99
|
52 Week Low
05/25/12 - $25.41
|
|
|
Market Cap
950.3M
|
Average Volume 10 Days
133.6K
|
|
|
EPS TTM
$1.53
|
Shares Outstanding
28.2M
|
|
|
EX-Date
--
|
P/E TM
22.0x
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
arthrocare corp (ARTC) Related Businessweek News
No Related Businessweek News Foundarthrocare corp (ARTC) Details
ArthroCare Corporation, medical device company, engages in the development, manufacture, and marketing of surgical products based on its Coblation technology in the Americas and internationally. It offers sports medicine products, including ArthroWands that features Coblation based specialized disposable energy-based surgical wands for single patient use to treat shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and soft-tissue fixation products, such as knotless and traditional anchors for rotator cuff and labrum repairs in the shoulder, screws for ligament reconstruction in the knee, and arthroscopic suture passers, as well as reusable hand-held instruments, procedural kits, and accessories. The company also provides ear nose and throat products consisting of suction wands, channeling wands, and excision wands; carboxymethyl-cellulose based packing and tamponade products that are used in nosebleed or epistaxis, as well as in treatments in an emergency room setting or surgicenter; dissolvable Stammberger sinus dressing and sinu knits to control minor bleeding, facilitate epithelial healing, and preserve the spatial integrity of the sinus area; and epistaxis balloon tamponade products for the hospital emergency room environment to control severe nosebleeds. In addition, it offers SpineWand devices to treat soft tissue conditions in spine; Plasma Disc decompression SpineWands for treating contained herniated discs; Cavity SpineWand to reduce the size of malignant lesions in the vertebrae of patients suffering from spinal compression fractures; and WoundWand for wound debridement in acute and chronic wounds and wound cleansing by removal of necrotic tissue. The company sells its products to surgeons and specialized medical professionals through sales representatives, and independent sales agents and distributors. ArthroCare Corporation was founded in 1993 and is headquartered in Austin, Texas.
arthrocare corp (ARTC) Top Compensated Officers
arthrocare corp (ARTC) Key Developments
ArthroCare Corporation announced unaudited consolidated financial results for the first quarter ended March 31, 2013. Total revenue for the first quarter of 2013 was $92.3 million, compared to $92.9 million for the first quarter of 2012, a decrease of less than 1%. Income from operations for the first quarter of 2013 was $13.5 million compared to $17.4 million for the same period in 2012. Net income available to common stockholders was $10.3 million or $0.30 per basic and diluted share in the first quarter of 2013, compared to $12.1 million, or $0.36 per basic and diluted share in the first quarter of 2012. Income from continuing operations before income taxes was $14 million against $17.8 million a year ago. Non-GAAP adjusted income from operations was $17.4 million against $18.5 million a year ago. Cash flows provided by operating activities for the quarter ended March 31, 2013 was $19.5 million compared to cash used in operations of $55.5 million for the quarter ended March 31, 2012 which included the payment of $74 million required to settle the private securities class actions against the Company. Adjusted for this payment, cash flows provided by operating activities would have been $18.5 million in the first quarter of 2012. For full year 3013, the company expects overall revenue growth to be between 2% and 4.5%. Operating margin outlook for 2013 was to achieve an adjusted operating margin equivalent to 2011 operating margin, which was 18.4%. Normal effective tax rate would be approximately 27%.
ArthroCare Corporation, Q1 2013 Earnings Call, May 08, 2013
ArthroCare Corporation announced that they will report Q1, 2013 results at 5:00 PM, Eastern Standard Time on May 07, 2013
| Recently Viewed | |||
| ARTC:US | $33.70 USD | +0.06 | |
| Company | Last | Change |
| ICU Medical Inc | $70.68 USD | +1.80 |
| Merit Medical Systems Inc | $9.96 USD | -0.01 |
| Orthofix International NV | $26.52 USD | -0.34 |
| Tornier NV | $16.92 USD | +0.02 |
| Wright Medical Group Inc | $23.91 USD | +0.18 |
| View Industry Companies | ||
Industry Analysis
ARTC
Industry Average
| Valuation | ARTC | Industry Range |
| Price/Earnings | 28.3x |
|
| Price/Sales | 2.6x |
|
| Price/Book | 2.5x |
|
| Price/Cash Flow | 19.5x |
|
| TEV/Sales | 1.7x |
|
Post a JobJobs
- Norcross, GA | ArthroCarePosted: May 15
- Norcross, GA | ArthroCarePosted: Apr 24
- Norcross, GA | ArthroCarePosted: Apr 29
- Austin, TX | ArthroCarePosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact ARTHROCARE CORP, please visit www.arthrocare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








